Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-04-23
1991-08-06
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
548496, A61K 3702, C07D20904
Patent
active
050378082
ABSTRACT:
Novel peptide mimetic compounds are provided which have useful activity as inhibitors of platelet aggregation. These compounds have the chemical structure ##STR1## wherein x=4 to 8,
REFERENCES:
patent: 4051141 (1977-09-01), Castaigne
patent: 4127580 (1978-11-01), Braye
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4589881 (1986-05-01), Fierschbacher et al.
patent: 4614517 (1986-09-01), Ruoslahti et al.
patent: 4661111 (1987-04-01), Ruoslahti et al.
patent: 4683291 (1987-07-01), Zimmerman et al.
patent: 4857508 (1989-08-01), Adams et al.
patent: 4879237 (1989-11-01), Rouslahti et al.
Kloczewiak et al., Biochem, 23, 1767-1774 (1984).
Plow et al., Proc. Natl. Acad. Sci. 82, 8057-8061 (1984).
Ruggeri et al., Ibid. 83, 5708-5712 (1986).
Ginsberg et al., J. Biol. Chem. 260(7), 3931-3936 (1985).
Haverstick et al., Blood 66(4), 946-952 (1985).
Adams Steven P.
Garland Robert B.
Miyano Masateru
Tjoeng Foe S.
G. D. Searle & Co.
Ivy C. Warren
Meyer Scott J.
Monsanto Co.
Northington-Davis Zinna
LandOfFree
Indolyl platelet-aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolyl platelet-aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolyl platelet-aggregation inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987065